📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Harnessing CD8+CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease. (2021)

First Author: Ceeraz S

Attributed to: The MUC1-ST/Siglec-9 innate check point axis in cancer: prevalence, prognostic significance and potential therapeutics. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cells10112973

PubMed Identifier: 34831195

Publication URI: http://europepmc.org/abstract/MED/34831195

Type: Journal Article/Review

Volume: 10

Parent Publication: Cells

Issue: 11

ISSN: 2073-4409